Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@1509 and playingtheodds
My posts are my own views, but pls don’t risk your hard earned by reading a post. It’s always best to do your own research too. I’ve tried to be balanced here and credit is due to NCYT. There was a period when they were stuck at 270p, and not much was happening whilst other shares were rising. Now it’s their turn.
Bottom line the cream always rises to the top. The ****ty fake ceos of some of these aim covid stocks eventually get found out. I’m hoping ODX will be one of the good investments.
Thanks Safy , I have confidence in ODX but the more I read about tendering or lack of it the more I worry that the govt and its financial backers are the biggest threat to ODX making a commercial breakthrough. I hope to be proved wrong.
Hopeingmore
I think waiting to see if your portfolio will peak at the same time so you see a nice balance is like waiting for a perfect storm.
Lovely if it happens and would put a big smile on my face
I have noticed that when DDDD go up ODX go down and vice versa so my portfolio seems to stay roughly the same on up or down days
Pearsing81 is spam filtered
Safy
Nice post .
You have given good positive information about ODX.
On my feed for the ODX share price, NCYT come up as a comparison and some days when ODX are down you see NCYT surging ahead and I think have I backed the right horse?
Your post gives me confidence again to stick with ODX
Thanks
NCYT had a test which was as good as any at the time (not very good) but they were in a group which consisted of a handful that had a test which worked.
When they were applying for clearances it used to take 2-3 days for FDA. Now it takes 3-4 months plus political bias. So this gave them market advantage, they were there first and were first to market.
Since then, they have improved their tests significantly and obviously being first to market has meant they have the cash flow coming in and established sales channels.
Once a testing system has been configured to work with a particular test, there is little appetite to change. That’s where they have an advantage over others.
Their skills and expertise have allowed them to work on more covid products too.
However as this is an ODX board so it is prudent to know for the antibody LFT we are ahead of them. Miles ahead. And let’s not forget Mologic antigen LFT. Mologic are quite advanced there too.
LFT is the end game, pregnancy type tests. Of two possible tests we already have one, and this test also happens to be one of the best in the world. Next stop Mologic LFT...
ODX - fingers in all the tests
I am no expert, so apologies if I am wrong, but I did make a nice profit on NCYT on their second peak. I believe they had an older style lab test ready to go straight into the approvals process hence early off the mark.
How did they get the product to market so soon and why stifle the urgent need for tests through endless amounts of red tape now. This govt are a disgrace and yet the sheep will still vote for them knowing that they have our best interests at heart not the pockets of the wealthy. Sorry but we are hurtling into a disaster with an eejit at the helm . It's like a real life Blackadder.